Tumor Microenvironment Alters Chemoresistance of Hepatocellular Carcinoma Through CYP3A4 Metabolic Activity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Microenvironment Alters Chemoresistance of Hepatocellular Carcinoma Through CYP3A4 Metabolic Activity
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-28
DOI
10.3389/fonc.2021.662135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcriptional regulation of CYP3A4 by nuclear receptors in human hepatocytes under hypoxia
- (2020) Xuechun Yuan et al. DRUG METABOLISM REVIEWS
- The Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review
- (2020) Alican Özkan et al. Micromachines
- Combining Chemistry and Engineering for Hepatocellular Carcinoma: Nano-Scale and Smaller Therapies
- (2020) Danielle L. Stolley et al. Pharmaceutics
- In Vitro Vascularized Liver and Tumor Tissue Microenvironments on a Chip for Dynamic Determination of Nanoparticle Transport and Toxicity
- (2019) Alican Ozkan et al. BIOTECHNOLOGY AND BIOENGINEERING
- Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin Induced CYP3A4 and MDR1 Gene Expression
- (2019) Kodye L Abbott et al. MOLECULAR PHARMACOLOGY
- Human three-dimensional in vitro model of hepatic zonation to predict zonal hepatotoxicity
- (2019) Jaehwan Ahn et al. Journal of Biological Engineering
- A novel 3D in vitro model of glioblastoma reveals resistance to temozolomide which was potentiated by hypoxia
- (2019) Ahmed Musah-Eroje et al. JOURNAL OF NEURO-ONCOLOGY
- Systemic treatment of advanced hepatocellular cancer: new hope on the horizon
- (2019) Rachael Chang Lee et al. Expert Review of Anticancer Therapy
- Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
- (2019) Philippe Merle et al. Lancet Gastroenterology & Hepatology
- Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma
- (2019) Ghassan K. Abou-Alfa et al. JAMA Oncology
- Evaluation of human primary intestinal monolayers for drug metabolizing capabilities
- (2019) Jennifer E. Speer et al. Journal of Biological Engineering
- Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight
- (2018) K. Lohitesh et al. Cancer Cell International
- Liver ‘organ on a chip’
- (2018) Colin H. Beckwitt et al. EXPERIMENTAL CELL RESEARCH
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma
- (2018) Iftikhar Ali Khawar et al. NEOPLASIA
- Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours
- (2018) Zeribe C. Nwosu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin
- (2018) M. Hunter Joyce et al. Frontiers in Oncology
- Hypoxia increases chemoresistance in human medulloblastoma DAOY cells via hypoxia‑inducible factor 1α‑mediated downregulation of the CYP2B6, CYP3A4 and CYP3A5 enzymes and inhibition of cell proliferation
- (2018) Jes�s Valencia‑Cervantes et al. ONCOLOGY REPORTS
- Liver inflammation and fibrosis
- (2017) Yukinori Koyama et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential response to doxorubicin in breast cancer subtypes simulated by a microfluidic tumor model
- (2017) Altug Ozcelikkale et al. JOURNAL OF CONTROLLED RELEASE
- Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells
- (2017) A J Rice et al. Oncogenesis
- Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply
- (2017) Ken Liu et al. Clinical and Translational Gastroenterology
- Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
- (2016) Jessica L. Petrick et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).
- (2016) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias
- (2016) Jae-Won Shin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatocellular carcinoma: From diagnosis to treatment
- (2016) Miral Sadaria Grandhi et al. SURGICAL ONCOLOGY-OXFORD
- The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance
- (2016) Susan Breslin et al. Oncotarget
- The role of p53 in cancer drug resistance and targeted chemotherapy
- (2016) Karin Hientz et al. Oncotarget
- Characterization of a functional C3A liver spheroid model
- (2016) Harriet Gaskell et al. Toxicology Research
- Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
- (2015) Helena Doktorova et al. BIOMEDICAL PAPERS-OLOMOUC
- Liver cancer biopsy - back to the future?!
- (2015) Michael Torbenson et al. HEPATOLOGY
- Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients
- (2015) T. Yan et al. MOLECULAR CANCER THERAPEUTICS
- Tunable Collagen I Hydrogels for Engineered Physiological Tissue Micro-Environments
- (2015) Elizabeth E. Antoine et al. PLoS One
- Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels
- (2014) Melina M. Malinen et al. BIOMATERIALS
- Differential Expression of Cytochrome P450 Enzymes in Normal and Tumor Tissues from Childhood Rhabdomyosarcoma
- (2014) Dora Molina-Ortiz et al. PLoS One
- Sorafenib Metabolism Is Significantly Altered in the Liver Tumor Tissue of Hepatocellular Carcinoma Patient
- (2014) Ling Ye et al. PLoS One
- Effects of hypoxia on human cancer cell line chemosensitivity
- (2013) Sara Strese et al. BMC CANCER
- Cytochrome P450-activated prodrugs
- (2013) Paul R Ortiz de Montellano Future Medicinal Chemistry
- Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation
- (2013) Hyun Jung Kim et al. Integrative Biology
- AlgiMatrix™ Based 3D Cell Culture System as an In-Vitro Tumor Model for Anticancer Studies
- (2013) Chandraiah Godugu et al. PLoS One
- Chemoembolization of Hepatocellular Carcinoma
- (2013) Pasquale Petruzzi et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability
- (2012) Manuel Rodríguez-Perálvarez et al. ANNALS OF SURGICAL ONCOLOGY
- Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system
- (2012) Liang Ma et al. BIOMATERIALS
- Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
- (2012) R. Coriat et al. MOLECULAR CANCER THERAPEUTICS
- Up-regulation of CYP expression in hepatoma cells stably transfected by chimeric nuclear receptors
- (2010) Jenni Küblbeck et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- An Akt/Hypoxia-Inducible Factor-1 /Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells
- (2009) C. K. Lau et al. CLINICAL CANCER RESEARCH
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1α involvement in CYP3A4 repression
- (2009) Claire Legendre et al. EUROPEAN JOURNAL OF CANCER
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started